# FDA Inspection 808180 - Vitalant - November 21, 2012

Source: https://www.keypedia.com/records/fda_inspections/vitalant/38af8e4f-9a5d-42eb-8367-7754bf310ff2
Source feed: FDA_Inspections

> FDA Inspection 808180 for Vitalant on November 21, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 808180
- Company Name: Vitalant
- Inspection Date: 2012-11-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1305000 - 2026-02-12](https://www.keypedia.com/records/fda_inspections/vitalant/555876f1-75ff-4942-b538-2e8253f5aa05)
- [FDA Inspection 1305000 - 2026-02-12](https://www.keypedia.com/records/fda_inspections/vitalant/21b21c8a-e99a-4c54-bd41-237aa4a94f8d)
- [FDA Inspection 1162743 - 2022-02-09](https://www.keypedia.com/records/fda_inspections/vitalant/42888110-93f8-46d8-8085-3d3f7074c318)
- [FDA Inspection 1162743 - 2022-02-09](https://www.keypedia.com/records/fda_inspections/vitalant/956d7693-ff81-4fa5-9548-56a91cbbe8da)
- [FDA Inspection 1074889 - 2018-12-04](https://www.keypedia.com/records/fda_inspections/vitalant/54e74d84-3d6f-4183-ae89-2fd8024d04d4)

Company: https://www.keypedia.com/companies/vitalant/6556e70e-5519-45d8-96e5-dd55f22ef944

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d